Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations.
Autor: | Lindley, Anouk1, Prager, Gerald2, Bitzer, Michael3, Burn, Timothy C.1, Lihou, Christine F.1, Croft, Elisabeth1 erichards@incyte.com |
---|---|
Zdroj: | Cancer Research & Treatment. Jul2024, Vol. 56 Issue 3, p847-855. 9p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |